Etonogestrel/Testosterone Undecanoate

依托孕烯/十一酸睾酮

Report date: 2022/07/04 19:38:02

Base Information

Drug NameEtonogestrel/Testosterone Undecanoate
Drug Alias Name十一酸睾酮/依托孕烯Etonogestrel+Testosterone Undecanoate十一酸睾酮+依托孕烯Testosterone Undecanoate+Etonogestrel依托孕烯+十一酸睾酮 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsAndrogen Receptor agonistsEstrogen receptors agonists
TargetsAndrogen ReceptorEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsContraception
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes EtonogestrelTestosterone Undecanoate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme CorpBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AGOrganon & Co
Active IndicationsN/A
Inactive IndicationsContraception

Other Information

ATC CodeN/A
Related LinksN/A